[登录] [免费注册]
试剂仪器网
位置:首页 > 资料中心 > 化工字典 > 1508-65-2
关键词:       仅模糊查询
CAS: 1508-65-2
分子式: C22H32ClNO3
分子量: 393.95
沸点: 494.4ºC
熔点: 122-124°C
中文名称: 
盐酸奥昔布宁
α-环己基-α-羟基-苯乙酸-4-二乙氨基-2-丁炔酯盐酸盐
英文名称: 
cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester, hydr
4-diethylamino-2-butynyl phenyl(cyclohexyl)glycolate hydrochloride
alpha-phenylcyclohexaneglycolic acid 4-(diethylamino)-2-butynyl ester hydroch
ditropan
mj 4309-1
oxibutinina hydrochloride
oxybutynin chloride
oxybutynin hydrochloride
tropax
α-Phenylcyclohexaneglycolic acid 4-(diethylamino)-2-butynyl ester hydrochloride
用途: 解痉药,用于尿急、尿频、尿失禁、夜尿和遗尿等。
推荐供应商
货号品牌产品名称规格包装、参考价格详情
O798068MACKLIN盐酸奥昔布宁10mM in DMSO136元/1ml;   展开
储存:-20°C
O859252MACKLIN盐酸奥昔布宁≥99%136元/1g;   620元/5g;   展开
储存:室温,干燥
状态:白色固体
O0451TCIOxybutynin Hydrochloride>98.0%(HPLC)990元/1G;   4150元/5G;   展开

基本信息

纯度/分析方法>98.0%(HPLC)
分子式/分子量C22H31NO3・HCl = 393.95
外观与形状(20℃)固体
储存在惰性气体下存放于惰性气体之中
应避免的情况光,湿气 (吸湿)
Reaxys-RN4833152
MDL编号MFCD00072150

技术规格

AppearanceWhite to Orange to Green powder to crystal
Purity(HPLC)min. 98.0 area%
Purity(Nonaqueous Titration)min. 96.0 %
Specific rotation [a]20/D-0.1 to +0.1 deg(C=10, water)

物性(参考值)

熔点127 ℃(dec.)

安全信息

图形或危害标志
信号词警告
危险性说明H302 : 吞咽有害。
防范说明P501 : 将内装物/容器送到批准的废物处理厂处理。
P270 : 使用本产品时不要进食、饮水或吸烟。
P264 : 作业后彻底清洗皮肤。
P301 + P312 + P330 : 如误吞咽:如感觉不适,呼叫急救中心/医生。漱口。

相关法规

RTECS#GV2800000
200423J&KOxybutynin Hydrochloride99%819元/500MG;   1214元/1G;   4176元/5G;   展开

基本信息

分子式C22H31NO3·HCl
分子量393.95
MDL编码MFCD00072150
EINECS 编号216-139-7

安全信息

图形或危害标志
提示语Warning
危险说明H302
防范说明P264
P270
P301+P312
P330
P501
WGK3
RTECSGV2800000
C46350Alfa AesarOxybutynin Hydrochloride3246元/1g;   11137元/5g;   43740元/25g;   展开

基本信息

Ref#
46350

分子式
C22H31NO3.HCl

分子量
1277.13

GHS危害和防范说明

GHS符号

Hazard Statements
H302
Harmful if swallowed.

Precautionary Statements
P301+P330+P331 P312 P264

O0288000Oxybutynin HydrochlorideEuropean Pharmacopoeia (EP) Reference Standard1277.32元/ ;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。

包装

Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C22H31NO3 · HCl
分子量393.95
MDL编号MFCD00072150
PubChem化学物质编号329818836
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameEDQM
application(s)pharmaceutical (small molecule)
格式neat
储存温度2-8℃
SMILES stringCl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2
InChI1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H
InChI keySWIJYDAEGSIQPZ-UHFFFAOYSA-N
Gene Informationhuman ... CHRM2(1129), CHRM3(1131)

安全信息

象形图GHS07
警示用语:Warning
危险声明H302
预防措施声明P264 - P270 - P301 + P312 - P501
危险分类Acute Tox. 4 Oral
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
O2881Sigma-AldrichOxybutynin chloride≥98% (TLC), powder904.42元/500 MG;   1341.59元/1 G;   4614.63元/5 G;   展开

产品说明

包装

1, 5 g in glass bottle
500 mg in glass bottle

生化/生理作用

毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。

特点和优势

This compound was developed by Johnson & Johnson. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

基本信息

经验(实验)分子式C22H31NO3 · HCl
分子量393.95
EC 号216-139-7
MDL编号MFCD00072150
PubChem化学物质编号57654480
NACRESNA.77

产品性质

质量水平200
测定≥98% (TLC)
形式powder
颜色 white
溶解性H2O: 50 mg/mL
创始人Johnson & Johnson
SMILES stringCl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2
InChI1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H
InChI keySWIJYDAEGSIQPZ-UHFFFAOYSA-N
Gene Informationhuman ... CHRM1(1128), CHRM2(1129), CHRM3(1131), CHRM4(1132), CHRM5(1133)

安全信息

象形图GHS07
警示用语:Warning
危险声明H302
预防措施声明P264 - P270 - P301 + P312 - P501
危险分类Acute Tox. 4 Oral
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
个人防护装备dust mask type N95 (US), Eyeshields, Faceshields, Gloves
O5015Sigma-AldrichOxybutynin chloridemeets EP, USP testing specifications1785.42元/1 G;   5408.06元/5 G;   展开

产品说明

包装

1, 5 g in glass bottle
500 mg in glass bottle

生化/生理作用

毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。

基本信息

经验(实验)分子式C22H31NO3 · HCl
分子量393.95
EC 号216-139-7
MDL编号MFCD00072150
PubChem化学物质编号24898008
NACRESNA.21

产品性质

质量水平200
agencyUSP/NF
meets EP testing specifications
meets USP testing specifications
application(s)pharmaceutical (small molecule)
储存温度room temp
SMILES stringCl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2
InChI1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H
InChI keySWIJYDAEGSIQPZ-UHFFFAOYSA-N
Gene Informationhuman ... CHRM2(1129), CHRM3(1131)

安全信息

象形图GHS07
警示用语:Warning
危险声明H302
预防措施声明P264 - P270 - P301 + P312 - P501
危险分类Acute Tox. 4 Oral
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
个人防护装备dust mask type N95 (US), Eyeshields, Faceshields, Gloves
PHR2547SupelcoOxybutynin chloridecertified reference material, pharmaceutical secondary standard1966.23元/500 MG;   展开

产品说明

一般描述

Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

生化/生理作用

毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。

分析说明

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

其他说明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

基本信息

经验(实验)分子式C22H31NO3 · HCl
分子量393.95
MDL编号MFCD00072150

产品性质

等级certified reference material
pharmaceutical secondary standard
描述Pharmaceutical Secondary Standard; Certified Reference Material
形式solid
CofAcurrent certificate can be downloaded
包装pkg of 500 mg
药典可追溯性traceable to PhEur O0288000
traceable to USP 1485103
储存温度2-30℃
SMILES stringCl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2
InChI1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H
InChI keySWIJYDAEGSIQPZ-UHFFFAOYSA-N

安全信息

象形图GHS07
警示用语:Warning
危险声明H302
预防措施声明P264 - P270 - P301 + P312 - P501
危险分类Acute Tox. 4 Oral
储存分类代码13 - Non Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
1485103USPOxybutynin chlorideUnited States Pharmacopeia (USP) Reference Standard3231.47元/200 MG;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。

分析说明

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他说明

USP issued SDS can be found here.
Sales restrictions may apply.

基本信息

经验(实验)分子式C22H31NO3 · HCl
分子量393.95
MDL编号MFCD00072150
PubChem化学物质编号329750639

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameUSP
application(s)pharmaceutical (small molecule)
格式neat
SMILES stringCl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2
InChI1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H
InChI keySWIJYDAEGSIQPZ-UHFFFAOYSA-N
Gene Informationhuman ... CHRM2(1129), CHRM3(1131)

安全信息

象形图GHS07
警示用语:Warning
危险声明H302
预防措施声明P301 + P312 + P330
危险分类Acute Tox. 4 Oral
储存分类代码13 - Non Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
BP701Oxybutynin HydrochlorideBritish Pharmacopoeia (BP) Reference Standard1952.55元/100 MG;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。

包装

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C22H31NO3 · HCl
分子量393.95
EC 号204-717-1
MDL编号MFCD00072150
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameBP
格式neat
SMILES stringCl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2
InChI1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H
InChI keySWIJYDAEGSIQPZ-UHFFFAOYSA-N
Gene Informationhuman ... CHRM2(1129), CHRM3(1131)

安全信息

象形图GHS07
警示用语:Warning
危险声明H302
预防措施声明P301 + P312 + P330
危险分类Acute Tox. 4 Oral
储存分类代码13 - Non Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
Y0002275Oxybutynin hydrochloride for system suitabilityCRS, European Pharmacopoeia (EP) Reference Standard1341.2元/ ;   展开

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pha

生化/生理作用

毒蕈碱型乙酰胆碱受体拮抗剂;可能通过下调生长促进基因,抑制膀胱平滑肌细胞的增殖。

包装

Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C22H31NO3 · HCl
分子量393.95
MDL编号MFCD00072150

产品性质

manufacturer/tradenameEDQM
储存温度2-8℃
SMILES stringCl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2
InChI1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H
InChI keySWIJYDAEGSIQPZ-UHFFFAOYSA-N

安全信息

象形图GHS07
警示用语:Warning
危险声明H302
预防措施声明P264 - P270 - P301 + P312 - P501
危险分类Acute Tox. 4 Oral
储存分类代码11 - Combustible Solids
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
CAS号首数字顺序排列: 1 2 3 4 5 6 7 8 9